Integrated genomics and transcriptomics reveal key events in pancreatic neuroendocrine neoplasm
Authors:
Open Access
- 19 May 2026
- journal article
- research article
- Published by Springer Nature in BMC Biology
- Vol. 24 (1)
Abstract
Pancreatic neuroendocrine neoplasm (PanNEN) represents the second most common epithelial neoplasm of the pancreas, characterized by remarkable heterogeneitKeywords
This publication has 44 references indexed in Scilit:
- MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide ResistanceAdvanced Science, 2024
- Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?Endocrine Pathology, 2024
- Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United StatesJAMA Network Open, 2021
- Conserved pan-cancer microenvironment subtypes predict response to immunotherapyCancer Cell, 2021
- Epidemiological trends of neuroendocrine tumours over three decades in Queensland, AustraliaCancer Epidemiology, 2019
- Whole-genome landscape of pancreatic neuroendocrine tumoursNature, 2017
- Sequencing Structural Variants in Cancer for Precision TherapeuticsTrends in Genetics, 2016
- Landscape of somatic mutations in 560 breast cancer whole-genome sequencesNature, 2016
- Punctuated Evolution of Prostate Cancer GenomesCell, 2013
- Deciphering Signatures of Mutational Processes Operative in Human CancerCell Reports, 2013